Werewolf Therapeutics, Inc. (HOWL) AI Dilution Summary

Cash was $21,987,000 at the 2026-06-30 balance-sheet date. The company's funding channel is an active at-the-market program with Leerink Partners LLC, authorised to $12,468,318. The filings record $60,561,600 sold to date under the program.